Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - June 2013

5th Annual Drug Development Congress 2013

10 Jun 2013 - 11 Jun 2013 - Geneva, Switzerland

Bookmark and Share

Oxford Global Conferences are proud to present the 5th Annual Drug Development Congress, taking place on the 10th & 11th June in Geneva.

It is estimated that the average drug costs the world’s leading pharmaceutical companies at least $4 billion to develop. Amid fears that the current large pharma model is not working, this event focuses on attempts to break down discovery and development boundaries and promote knowledge share between therapy areas.

On Day One, our expert speakers will discuss key areas for improvement in drug development, including translational modelling, safety & efficacy testing and reducing timelines for biopharmaceutical pipelines. Topics will include assay development, pharmacokinetic challenges and updates on the latest NGS applications.

Day Two will cover the latest methods to improve decision making in drug development; from advances in biomarker technology, to the integration of safety studies earlier in the pipeline. Our expert speakers will also present collaboration case studies, discussing both external and internal attempts to harness complimentary skills and reduce late stage failure.

To maintain the extensive networking opportunities enjoyed by last year’s delegates, the development congress will once again be co-located with our discovery summit. The 14th Annual Drug Discovery Leaders’ Summit has a long-held association with the leaders in medicinal chemistry and drug design. This year’s event will focus on innovation. Experts will discuss how new developments in screening, assay development, structure-activity analysis and anti-target effect prediction will influence the success of discovery portfolios.

Further information
Scientific News
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Editing Gene Mutations in Anemia
Researchers successfully use a new gene editing strategy to correct mutations that cause a form of anemia.
Genes Help Track Odd Migrations of Zika Mosquitoes
Study shows that mosquitoes carrying Zika virus or Dengue fever a genetically distinct around the world.
Nanomedicine Aims to Improve HIV Drug Therapies
New research aims to improve the administration and availability of drug therapies to HIV patients using nanotechnology.
Tumor Markers Reveal Lethality Of Bladder Cancers
Researchers found that detection of certain tumor cells in early stage cancers helps identify high-risk cancers.
Gene Editing Corrects Sickle Cell Mutation
Researchers demonstrate a potential pathway to developing gene-editing treatments for sickle cell disease.
Driving Mosquito Evolution to Fight Malaria
Researchers propose insect repellent in conjunction with insecticides to extend current insecticide lifetime.
Lab-on-a-Chip to Help Detect Cancer
In this podcast, we speak to Gustavo Stolovitsky to learn about his career and the work he is doing at IBM Research.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos